[ET Net News Agency, 1 April 2026] KEYMED BIO-B (02162) rose 10.7% to HK$67.2.
It hits an intra-day high of HK$67.2, hitting an 1-month high, and an intra-day low of HK$62.55. The total shares traded was 4.63 million, with a value of HK$300.17m. The active buy/sell ratio is 81:19, with net buying turnover of HK$177.52m. UBS accounts for greatest net responsive buying turnover of HK$6.17m, with volume weighted average price of HK$64.774. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of HK$67.21m, with volume weighted average price of HK$64.843. The stock has risen a combined 11.7% over the past 2 consecutive trading days.
Basic Information| Nominal | 67.200 | % Chg | +10.71% |
| High | 67.200 | Low | 62.550 |
| Shares Tr | 4.63m | Turnover | 300.17m |
| 10-D SMA | 57.120 | %H.V | 58.575 |
| 20-D SMA | 54.988 | VWAP | 64.810 |
| 50-D SMA | 54.916 | RSI14 | 73.988 |
Status: Hitting an 1-month high, active buy/sell ratio is 81:19, with net buying turnover of HK$177.52m, rising a combined 11.7% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| KEYMED BIO-B (02162) | 67.20 | +10.71 |
| INNOVENT BIO (01801) | 90.55 | +6.65 |
| XTALPI (02228) | 9.49 | +5.33 |
| WUXI XDC (02268) | 61.10 | +4.98 |
| WUXI BIO (02269) | 34.98 | +5.94 |
| WUXI APPTEC (02359) | 122.90 | +4.60 |
| BEONE MEDICINES (06160) | 184.10 | +7.28 |
| SKB BIO-B (06990) | 490.40 | +6.61 |
| AKESO (09926) | 139.40 | +7.07 |
| REMEGEN (09995) | 108.50 | +13.26 |
(ed)
